TORONTO and BENGALURU, India, Oct. 23, 2025 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: BIOCON), today ...

The FDA’s effort to curb high drug costs by accelerating approvals of cheaper medicines similar to expensive biologics will ...

The specificity of biologics can lead to better outcomes and fewer off-target effects compared to some broader-acting ...

In the last few weeks, Health Canada issued several decisions concerning biologics. On October 17, Health Canada approved, via a Notice of Compliance, Biocon Biologics Ltd.’s YESINTEK (ustekinumab ...

Global health issues, especially those affecting the world’s poor, rarely gain anywhere near the attention that the U.S. public and policymakers give to domestic concerns. However, in one small corner ...

In the relentless pursuit of better health outcomes, innovation must be embraced, and biologics represent a monumental leap forward in medical treatment. These aren’t mere drugs; they are ...

Over the past 15 years, treatment options for ulcerative colitis (UC) have expanded quite a bit. Among the most common options is a class of drugs called biologics. Biologics are derived from natural ...

It took years for Elle Moxley to get a diagnosis that explained her crippling gastrointestinal pain, digestion problems, fatigue, and hot, red rashes. And after learning in 2016 that she had Crohn’s ...

WUXI, China, Oct. 27, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed a remote GMP ...

RICHMOND, British Columbia, Feb. 13, 2025 (GLOBE NEWSWIRE) -- As the healthcare and supplement industries experience seismic shifts—driven by new U.S. tariffs, growing scrutiny on Big Pharma, and ...

This article originally appeared on PolitiFact. If you watch TV and don’t mute ads, you’ve probably heard of a few biologics. They’re drugs such as Humira for arthritis and Trulicity for Type 2 ...

The latest announcement is out from MustGrow Biologics ( (TSE:MGRO) ).